医学
肾功能
四分位间距
肾脏疾病
泌尿科
内科学
队列
比例危险模型
肾癌
外科
作者
Jitao Wu,Chalairat Suk‐Ouichai,Wen Dong,Elvis Caraballo Antonio,Ithaar Derweesh,Brian R. Lane,Sevag G. Demirjian,Jianbo Li,Steven C. Campbell
出处
期刊:BJUI
[Wiley]
日期:2017-09-10
卷期号:121 (1): 93-100
被引量:71
摘要
Objectives To evaluate predictors of long‐term survival for patients with chronic kidney disease primarily due to surgery ( CKD ‐S). Patients with CKD ‐S have generally good survival that approximates patients who do not have CKD even after renal cancer surgery ( RCS ), yet there may be heterogeneity within this cohort. Patients and Methods From 1997 to 2008, 4 246 patients underwent RCS at our centre. The median (interquartile range [ IQR ]) follow‐up was 9.4 (7.3–11.0) years. New baseline glomerular filtration rate ( GFR ) was defined as highest GFR between nadir and 6 weeks after RCS . We retrospectively evaluated three cohorts: no‐ CKD (new baseline GFR of ≥60 mL/min/1.73 m 2 ); CKD ‐S (new baseline GFR of <60 mL/min/1.73 m 2 but preoperative GFR of ≥60 mL/min/1.73 m 2 ); and CKD due to medical aetiologies who then require RCS ( CKD ‐M/S, preoperative and new baseline GFR both <60 mL/min/1.73 m 2 ). Analysis focused primarily on non‐renal cancer‐related survival ( NRCRS ) for the CKD ‐S cohort. Kaplan–Meier analysis assessed the longitudinal impact of new baseline GFR (45–60 mL/min/1.73 m 2 vs <45 mL/min/1.73 m 2 ) and Cox regression evaluated relative impact of preoperative GFR , new baseline GFR , and relevant demographics/comorbidities. Results Of the 4 246 patients who underwent RCS , 931 had CKD ‐S and 1 113 had CKD ‐M/S, whilst 2 202 had no‐ CKD even after RCS . Partial/radical nephrectomy ( PN / RN ) was performed in 54%/46% of the patients, respectively. For CKD ‐S, 641 patients had a new baseline GFR of 45–60 mL/min/1.73 m 2 and 290 had a new baseline GFR of <45 mL/min/1.73 m 2 . Kaplan–Meier analysis showed significantly reduced NRCRS for patients with CKD ‐S with a GFR of <45 mL/min/1.73 m 2 compared to those with no‐ CKD or CKD ‐S with a GFR of 45–60 mL/min/1.73 m 2 (both P ≤ 0.004), and competing risk analysis confirmed this ( P < 0.001). Age, gender, heart disease, and new baseline GFR were all associated independently with NRCRS for patients with CKD ‐S (all P ≤ 0.02). Conclusion Our data suggest that CKD ‐S is heterogeneous, and patients with a reduced new baseline GFR have compromised survival, particularly if <45 mL/min/1.73 m 2 . Our findings may have implications regarding choice of PN / RN in patients at risk of developing CKD ‐S.
科研通智能强力驱动
Strongly Powered by AbleSci AI